Sonova Holding (OTCMKTS:SONVY) Short Interest Update

Sonova Holding (OTCMKTS:SONVY) was the recipient of a large increase in short interest during the month of January. As of January 15th, there was short interest totaling 36,769 shares, an increase of 219.5% from the December 31st total of 11,510 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average trading volume of 45,081 shares, the days-to-cover ratio is presently 0.8 days. Based on an average trading volume of 45,081 shares, the days-to-cover ratio is presently 0.8 days. Currently, 0.0% of the company’s shares are sold short.

Analyst Upgrades and Downgrades

SONVY has been the subject of several analyst reports. Rothschild Redb raised Sonova from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. Royal Bank Of Canada upgraded shares of Sonova to a “moderate buy” rating in a research note on Tuesday, November 18th. Zacks Research lowered Sonova from a “hold” rating to a “strong sell” rating in a report on Tuesday, December 9th. Finally, BNP Paribas Exane assumed coverage on Sonova in a research report on Monday, October 20th. They set an “underperform” rating on the stock. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, four have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold”.

Sonova Stock Performance

Shares of OTCMKTS:SONVY opened at $54.89 on Thursday. The company has a 50 day moving average of $52.07 and a two-hundred day moving average of $54.78. The company has a quick ratio of 0.91, a current ratio of 1.24 and a debt-to-equity ratio of 0.51. Sonova has a 52-week low of $47.55 and a 52-week high of $71.50.

Sonova Company Profile

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.